Date :
Place : United States, Zurich, switzerland
Contact Person:Eevnt Manager
Description:
Defining the basic requirements of Good Clinical Practices Clinical Study Protocol Elements and Device Accountability Role of Institutional Review Board (IRB) and Informed Consent Principles of Ethics and Quality Control Determining the appropriate duties and oversight required of the sponsor, monitor, and investigators to ensure a high level of quality in a clinical trial Ensuring that quality practices are designed and implemented to guarantee compliant clinical trials Learning how to effectively manage a Sponsor, as well as, an FDA GCP inspection Read More : http://www.globalcompliancepanel.com/control/globalseminars/~product_id=900976SEMINAR?allconferencealerts_SEODeadline for abstracts/proposals : 13th June 2017
Organized By :NetZealous DBA as GlobalCompliancePanel
Keynote Speakers : David R. Dills, Global Regulatory Affairs & Compliance Consultant currently provides regulatory affairs and compliance consultative services for early-stage and established Class I/II/III device, IVD, biopharmaceutical, cosmetics and nutraceutical manufacturers on the global landscape, and has an accomplished record with more than 27 years
Conference Highlights :Clinical Research Associates who want a greater understanding of the medical device clinical trial process and their role in it Clinical Project Managers who are taking on a wider range of responsibilities and need to gain a greater understanding of the regulatory and practical issues involved in medical device clinical trials
Venue :Zürich, Switzerland
Check the event website for more details.